The Cost Utility of Bupropion in Smoking Cessation Health Programs

This publication has 19 references indexed in Scilit:

• WHO Framework Convention on Tobacco Control: development of an evidence based global public health treaty
  BMJ, 2003
• Selected major risk factors and global and regional burden of disease
  Published by Elsevier ,2002
• The clinical effectiveness and cost-effectiveness of bupropion and nicotine replacement therapy for smoking cessation: a systematic review and economic evaluation
  Health Technology Assessment, 2002
• Development of the health and economic consequences of smoking interactive model
  Tobacco Control, 2001
• The economic impact of smoking in Germany.
  European Respiratory Journal, 2000
• Smoking vs Other Risk Factors as the Cause of Smoking-Attributable Deaths
  JAMA, 2000
• Bupropion
  Drugs, 2000
• THE HUMAN AND FINANCIAL COSTS OF SMOKING
  Clinics in Chest Medicine, 2000
• Cost-Benefit Analysis of Sustained-Release Bupropion, Nicotine Patch, or Both for Smoking Cessation
  Preventive Medicine, 2000
• The decline of smoking among Swedish men
  International Journal of Epidemiology, 1998